Docket Room
S 5004·Federal·senate

Cancer Drug Parity Act of 2026

In CommitteeFiled Jul 15, 2026
Sponsor: Sen. Smith, Tina [D-MN] (D)
Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Jul 15, 2026

Summary

The bill amends ERISA so that any group health plan must provide cost‑sharing for oral anticancer medicines on terms no less favorable than for anticancer drugs administered by a health‑care provider. It applies to employees and their dependents who receive coverage through such plans. The goal is to prevent higher out‑of‑pocket costs for oral cancer pills compared with infused treatments.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when S 5004 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice